Evidence map›Paper›PMID 40735036›Full record

ArticleFrontiers in oncology2025

Case Report: Use of Tiao Wei Cheng Qi Decoction to relieve partial intestinal obstruction and enable surgical treatment in primary duodenal adenocarcinoma.

Ziyao Li, Jiahang Li, Boyang Li, Yingying Sun, Changcheng Wang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ziyao LiDepartment of General Surgery, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Jiahang LiSchool of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Boyang LiDepartment of General Surgery, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yingying SunDepartment of General Surgery, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Changcheng WangDepartment of General Surgery, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary duodenal adenocarcinoma (PDA) is rare and highly invasive malignancies. The onset of the disease is insidious. Patients are often diagnosed when digestive obstruction occurred, leading to poor nutritional status and reduced tolerance for surgical trauma. Additionally, patients commonly experience fluid depletion and gastric drying, which is recognized as a pattern of gastric dryness and fluid injury. This article presents a successful case treated with the modified Decoction for Regulating the Stomach and Resolving Phlegm Formula combined with partial duodenectomy, summarizes both Chinese and Western medical diagnostic and treatment strategies for this disease, and provides valuable clinical experience in treating it.

Indexed as

gastrointestinal obstructionpreoperative treatmentprimary duodenal adenocarcinoma (PDA)Tiao Wei Cheng Qi Decoction (TWCQD)traditional Chinese medicine (TCM)

Identifiers

PMID40735036
PMCPMC12303914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.